Disclosed herein are compounds represented by Structural Formula (I) and (I-A):
Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2, or simply “CRTH2” for the treatment of inflammatory disorders. The variables in Structural Formula (I) and (I-A) are defined herein.
本文公开了由结构式(I)和(I-A)表示的化合物:
同时,还公开了使用这些化合物抑制G蛋白偶联受体,称为
趋化因子受体同源分子表达在Th2上,或简称为“CRTH2”治疗炎症性疾病的方法。结构式(I)和(I-A)中的变量在本文中有定义。